Health&Beauty- Page 110

The FINANCIAL -- Bayer HealthCare announced today that the combination of oral Xarelto twice daily with standard antiplatelet therapy significantly reduced the composite primary efficacy endpoint of cardiovascular death, myocardial infarction and stroke in patients with acute coronary syndromecompared to those receiving

The FINANCIAL -- Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to standard antiplatelet therapy significantly reduced the composite primary efficacy endpoint of cardiovascular-related deaths, heart attacks or strokes in patients with acute coronary syndrome compared to those

The FINANCIAL -- The Ministry of Health Sunday announced a reduction in the prices of 115 generic drugs. The directive will be effective from January 1, 2012.

The FINANCIAL -- Hot pink lippy is the simplest way to update your look, and if you haven't already road-tested the mega make-up trend that simply won't go away, now is the time to give it a go.

The FINANCIAL -- BalancedMindz Inc announces the official launch of its new mental health website, balancedmindz.org. The site publishes cutting edge research and information related to the origins of mental illness, its diagnosis and treatment and more.

The FINANCIAL -- Amgen  and Pfizer Inc.  today announced results of the second and final period of the PRESERVE trial.

The FINANCUIAL -- Novartis announced today new pivotal Phase III data showing 45% of children with active systemic juvenile idiopathic arthritis were able to substantially reduce their use of oral corticosteroids  within 28 weeks of commencing treatment with ACZ885.

The FINANCIAL -- Janssen Pharmaceutica NV, today presented new data for INCIVO at the American Association for the Society of Liver Disease  Annual Meeting, highlighting the safety and efficacy of a telaprevir based regimen in cirrhotic patients who had previously failed treatment.

The FINANCIAL -- NEW YORK, NY. Nearly 40% of diagnosed "high-risk" atrial fibrillation patients in the 5EU are not taking an anticoagulant to prevent stroke, according to new findings from the National Health and Wellness Survey , conducted by Kantar Health and